Australia Medical Device Registration Cost 2026: Australian Sponsor Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How Much Does It Cost to Register a Medical Device in Australia in 2026?

For a single foreign-manufactured device entering the Australian market in 2026, expect a 3-year all-in budget of roughly USD 7,000–18,000 for a Class I or Class IIa device and USD 12,000–45,000 for a Class IIb, Class III, or AIMD device, excluding TGA government fees, conformity assessment audit costs paid to the TGA or to a recognized Conformity Assessment Body (CAB), and clinical evidence preparation. The wide range is not driven by the Therapeutic Goods Administration — TGA fees are published in Schedule 5 of the Therapeutic Goods (Medical Devices) Regulations 2002 and rise on an indexed schedule every 1 July. The range is driven almost entirely by how your Australian Sponsor bills you.

Three pricing models dominate the Australian Sponsor market today, and the difference between the cheapest and most expensive can exceed 5x over three years for the same scope of work:

Australian Sponsor Pricing Model	Year 1 Cost (Class IIa, 1 device)	Year 1 Cost (Class III, 1 device)	3-Year Total (Class IIa)	3-Year Total (Class III)
Hourly billing	$6,000–$12,000	$18,000–$32,000	$13,000–$22,000	$30,000–$50,000
Registration fee + lower annual	$5,000–$10,000	$9,000–$18,000	$9,000–$18,000	$16,000–$32,000
Flat all-inclusive annual fee	$2,000–$3,000	$2,000–$3,000	$6,000–$9,000	$6,000–$9,000

Australia is unusual among major medical device jurisdictions because the TGA charges two layers of government fees, not one — a per-application Application Assessment Fee at ARTG inclusion, and a recurring ARTG Listing Annual Fee invoiced every July for the life of the listing. Sponsor service fees stack on top as a third layer. This guide focuses on that third layer — the only one of the three where the buyer has real negotiating leverage.

Skip to Your Scenario

• Single Class IIa device, pre-revenue startup: Read Scenario A first — flat fee saves $7,000+ in Year 1 cash.
• Single Class III or AIMD device entering Australia: Read Scenario B — Year 1 burden under hourly is 70%+ of 3-year cost.
• Multi-device portfolio (3+ devices): Read Scenario C — tier discounts compound dramatically.
• Already have a Sponsor and want to switch: Skip to the Sponsor Switching Playbook.
• Issuing an RFP this week: Skip to the RFP Template and the 8 questions to ask.
• Want to validate the numbers: Read the Named Provider RFP Comparison.

Why Australian Sponsor Pricing Is Where Australia Budgets Win or Lose

Section 19A of the Therapeutic Goods Act 1989 requires every medical device imported, exported, or supplied in Australia to be entered on the ARTG by a sponsor — an individual resident in Australia or a body corporate incorporated under Australian law. A foreign manufacturer cannot hold the ARTG entry directly. The Sponsor signs all applications, submits adverse event reports under the Uniform Recall Procedure for Therapeutic Goods (URPTG), pays the annual ARTG charge, and is the entity TGA holds liable under Australian law.

The Australian Sponsor is not optional and not a one-time cost. ARTG entries are indefinite (subject to ongoing ARTG charge payment — no mandatory renewal cycle), so unlike a 510(k) consulting engagement that ends at clearance, the Sponsor is a permanent vendor relationship. Small pricing-model differences compound enormously over the device life.

It is also one of the few line items in international registration where the buyer has real negotiating leverage: scope is standardized (ARTG application, dossier upload, modifications, annual charge handling, vigilance, recalls), multiple firms can perform the role, switching is possible (with friction), and TGA's fee schedule is public so government fees cannot be marked up opaquely.

The catch: most Sponsor pricing is not published. You have to issue an RFP under NDA and compare proposals where every firm has a different scope-inclusion list, a different definition of "modification," and a different policy on annual-charge passthrough. That is the comparison this article is designed to short-circuit.

For the regulatory pathway itself — classification rules, conformity assessment options, MDSAP acceptance, EU CE / FDA / Health Canada / PMDA / HSA Comparable Overseas Regulator (COR) pathways, IVD risk classes, and clinical evidence — see Australia TGA Medical Device Registration: The Complete Guide. This article picks up where the regulatory guide stops: at procurement of Sponsor services.

The Three Australian Sponsor Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default model for small-to-mid Australian regulatory firms. Scope is captured in a Statement of Work; everything outside scope (including most "small" requests like ARTG label updates or annual charge processing) is billed at hourly rates that typically run AUD 200–600/hour or USD 130–385/hour depending on tier:

Consultant Tier	Australia Hourly Rate (2026, USD)	Typical Work
Tier 1 — senior regulatory strategist	$325–$385/hr	TGA strategy, COR pathway selection, SaMD reclassification, AIMD escalation
Tier 2 — regulatory specialist	$240–$290/hr	Dossier prep, conformity assessment evidence packaging, IVD reclassification
Tier 3 — associate / documentation	$130–$175/hr	TBS portal submissions, Australian declarations of conformity, label updates

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region.)

Why hourly is bad for buyers in practice:

• No incentive to be efficient. Every hour the Sponsor spends is revenue.
• Surprise invoices. "Quick check with the TGA" becomes 4 hours; a conformity assessment evidence review becomes 8 hours; the bill arrives 60 days after the work.
• Scope creep is invisible until it bills. A labeling change after a SaMD reclassification can be 2 hours or 20 — you find out after.
• Year 1 cash flow shock. TGA Business Services account setup, ARTG application, Australian Declaration of Conformity, dossier upload, initial labeling review, and sponsor-on-record paperwork are all front-loaded by definition.

A typical Class III or AIMD hourly engagement for a single device runs USD 18,000–32,000 in Year 1 and USD 4,000–9,000/year thereafter, with significant variance based on whether TGA issues Section 41JA requests for further information.

Model 2: Registration fee + lower annual maintenance

The dominant model for mid-to-large Australian Sponsor service firms — the structure used by most firms returned in standard "Australian Sponsor" Google searches. Buyer pays a one-time setup/registration fee plus a smaller recurring annual fee. Scope is bundled but each "extra" is an itemized add-on.

Component	Class I / IIa	Class IIb / III / AIMD
One-time setup fee (Sponsor onboarding)	$1,500–$3,500	$2,500–$5,000
Initial ARTG application filing	$2,000–$5,000	$4,500–$12,000
Annual maintenance fee	$1,500–$3,500	$3,000–$7,000
Per-modification fee	$400–$1,500	$1,500–$5,000
Per-IVD-reclassification handling	$500–$1,500	$1,500–$3,500
ARTG annual charge handling	$200–$500/year	$200–$500/year
Section 41JA TGA query response	hourly above scope	hourly above scope

The trap: the marketing message is "low annual fee," but Year 1 actual spend is typically USD 5,000–18,000 because every registration triggers setup + filing + dossier upload + annual charge prepayment in the same fiscal year you have not yet started selling.

Where this model fails buyers:

• Year 1 cash flow shock is structural. All major one-time fees fire before you have Australian revenue.
• Modifications are unbounded. A regulatory environment as active as Australia's between 2021 and 2026 (TGA Action Plan, SaMD reforms effective February 2021, IVD risk reclassification ordinances 2024–2025, Personalised Medical Devices framework, expanded CAB recognition) generates 1–3 modifications per device per year for active products. At AUD 800–4,000 each, that is a USD 1,500–8,000/year invisible tax.
• Section 41JA queries are billable. Every hour spent on TGA's request-for-further-information bills under hourly or reg-plus-annual; under flat fee, it should not.
• No relief on annual ARTG charges. Most Sponsors charge a USD 200–500 admin fee on top of the passthrough invoice.

Model 3: Flat all-inclusive annual fee

A newer pricing model where the Sponsor charges one annual fee covering the initial ARTG application, all modifications, all renewals, all TGA correspondence, and (where the manufacturer holds CE marking or another COR-recognized approval) the abbreviated COR submission pathway. Same number every year.

Two structural advantages:

1. The fee curve is flat instead of front-loaded. Year 1 cost equals Year N cost.
2. Sponsor incentives align with yours. Every additional hour they spend is pure cost to them, so they are motivated to be efficient and avoid Section 41JA queries.

The catch: flat-fee Sponsors typically require a multi-year contract and exclude TGA government fees, ARTG annual charges, conformity assessment audit fees, MDSAP audit fees, and clinical evaluation report preparation.

This model is rare. As of April 2026, Pure Global is the only major Australian Sponsor service provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing). Emergo Australia, MDSS, MedEnvoy, KD&A, Asia Actual, EMC Healthcare, Adjutor, Archer Emery, and Compliance MS all require an RFP under NDA before quoting.

Why this guide uses Pure Global as the worked example

Pure Global's published Australian Sponsor rates are the only flat-fee Sponsor rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. Not an endorsement; the published rates simply let us do an apples-to-apples cash flow comparison that would otherwise require RFPs to multiple firms under NDA. Industry ranges shown for hourly and front-loaded models are based on typical RFP responses and procurement data collected by MedDeviceGuide.

This article assumes the manufacturer holds (or is preparing) CE marking under EU MDR or an equivalent COR approval (FDA 510(k)/PMA, Health Canada licence, PMDA pre-market approval, HSA Class D registration), and the Sponsor's role is to file the abbreviated COR-pathway application, not to prepare a de novo conformity assessment. Full standard-pathway technical-file authoring is typically AUD 15,000–60,000 of one-off project fees on top of the recurring Sponsor relationship and is out of scope for this guide.

Recommended Reading

Colombia Medical Device Registration Cost 2026: INVIMA Representative Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

Regulatory Reimbursement & Market Access2026-04-24 · 42 min read

Pure Global Australia Sponsor Pricing (Published, April 2026)

Pure Global publishes a single Australian Sponsor tier table that applies across all medical device and IVD classifications. Unlike Brazil or the EU, where Class I/II and Class III/IV have separate pricing tables, Australia's tier structure is class-agnostic — the price scales only with the number of ARTG inclusions, not with risk class.

Australian Sponsor — Medical Devices and IVDs (All Classes)

Number of ARTG Inclusions	Annual Flat Fee (USD)
1	$2,000
2	$2,500
3	$3,000
4	$3,500
5	$4,000
6+	Custom quote

Included in the annual fee — per Pure Global's published price list:

• Preparation and submission of the registration (based on CE marking reference approval — i.e., Pure Global files the ARTG application via the abbreviated COR pathway against the manufacturer's existing CE certification; Pure Global is not preparing a de novo technical file)
• Modifications
• Renewals
• Correspondence with authorities

Inherent to the Australian Sponsor statutory role under Section 19A of the Therapeutic Goods Act 1989 (included by definition, not separately billable):

• Acting as the legal Australian Sponsor of record on the ARTG (Section 19A residency/incorporation requirement; the ARTG entry must be held by an Australian-resident individual or body corporate)
• Receiving vigilance and adverse-event correspondence from TGA as the Sponsor of record under the Uniform Recall Procedure for Therapeutic Goods (URPTG) and Therapeutic Goods (Medical Devices) Regulations 2002

Confirm scope before signing — these activities are not itemized on Pure Global's published price list, so verify in writing:

• Coordination/handling of the annual ARTG Listing Annual Fee invoice (whether passed through at cost without an admin fee — xlsx does not address this)
• Drafting (as opposed to receiving and routing) of vigilance reports, adverse-event submissions, and recall notifications to TGA — the published list specifies "correspondence with authorities" but does not enumerate report authorship
• Section 41JA request-for-further-information responses are likely covered under "correspondence with authorities," but volume caps (e.g., what counts as "reasonable scope") are not published — confirm in writing
• Australian Declaration of Conformity drafting where the manufacturer does not already supply one

Excluded — separately quoted on Pure Global's consulting menu (see Ad-Hoc Support below) or as a project quote:

• Standard-pathway technical-file authoring (no CE marking or COR-recognized approval available — separate project)
• Clinical Evaluation Report preparation under Essential Principle 14
• Out-of-scope work billed at USD 200/hour ad-hoc (see consulting menu)

Not included — government and third-party fees passed through at cost:

• TGA Application Assessment Fee (AUD 621–1,530 for MDs, AUD 1,187 for IVDs)
• TGA ARTG Listing Annual Fee (AUD 114–1,566 for MDs, AUD 893 for IVDs)
• TGA Application Audit Assessment Fee (Level 1 AUD 4,700; Level 2 AUD 17,288 for MDs; AUD 7,981 / 15,341–24,189 for IVDs)
• CAB fees if using the CAB-issued Conformity Assessment Document route
• MDSAP audit fees (USD 15,000–35,000 per annual surveillance, paid to AO)
• Importation handling, customs brokerage, GMP audits at manufacturer site

Ad-Hoc Support

USD 200/hour for out-of-scope work — materially below typical Australian regulatory consultancy rates (USD 240–385/hour for Tier 1–2 work).

Contract Terms

• Standard contract: 3 years.
• Annual contract option: available, but the first-year fee is increased by 50%.
• Early termination: allowed at any time with a 50% payoff of the remaining contract value.
• More than 5 ARTG inclusions: custom quote — incremental device pricing is generally negotiable on portfolio terms.

(Source: pureglobal.com/services/pricing, captured April 2026. Price list version 1.0, last updated 2026-01-12.)

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing. The scenarios below show the same scope — Sponsor service only, government and CAB/MDSAP fees excluded — under each model.

Scope assumption — read before relying on the flat-fee column. The Pure Global flat-fee numbers below assume (1) the manufacturer holds CE marking or another COR-recognized reference approval, so the ARTG application is filed via the abbreviated COR pathway — Pure Global's published "preparation and submission of the registration" inclusion is explicitly scoped "based on CE marking reference approval," meaning Pure Global is not authoring a de novo technical file; (2) Section 41JA TGA correspondence is treated as inside scope under the published "correspondence with authorities" line, but volume caps are not published — confirm in writing; (3) annual ARTG charge handling, vigilance/adverse-event report drafting, and Australian Declaration of Conformity drafting are shown as "included" in the tables for illustrative continuity with the hourly and reg-plus-annual columns, but these specific activities are not enumerated on Pure Global's published price list — confirm scope in writing before signing. If any of these fall outside scope in your contract, they are billed at the published USD 200/hour ad-hoc rate (still materially below typical Australian Tier 1–2 hourly rates).

Scenario A: Single Class IIa Device, 3-Year Total

CE-marked Class IIa device entering Australia under COR-reliance, 1–2 modifications/year, 1 Section 41JA query in Year 1.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 setup + ARTG filing	$7,800 (40 hrs × $195 blended)	$5,500 ($2,500 setup + $3,000 filing)	$2,000
Year 1 Section 41JA response + 1 modification	$2,000	$1,500 (1 mod × $750 + AI handling)	included
Year 1 total	$9,800	$7,000	$2,000
Year 2 maintenance	$3,400 (18 hrs blended)	$2,500 annual + $750 modification	$2,000
Year 3 maintenance	$3,400 (18 hrs blended)	$2,500 annual + $750 modification	$2,000
3-Year Total	$16,600	$13,500	$6,000
Year 1 share of 3-year spend	59%	52%	33%

The Year 1 burden under flat fee is $2,000 vs $9,800 under hourly — for the same regulatory output. That $7,800 not leaving the company in Year 1 is often the difference between launching in Australia this fiscal year and deferring 12–18 months.

Scenario B: Single Class III or AIMD Device, 3-Year Total

CE-marked Class III device (or AIMD) entering Australia under COR-reliance with TGA Application Audit Assessment Level 2, 2 modifications/year, 1 Section 41JA query.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 setup + ARTG filing + audit response	$22,000 (110 hrs × $200 blended)	$11,500 ($4,500 setup + $7,000 filing)	$2,000
Year 1 Section 41JA + audit support	$4,000	$2,500	included
Year 1 modifications	$1,800	$2,500 (2 mods × $1,250)	included
Year 1 total	$27,800	$16,500	$2,000
Year 2 maintenance	$5,500 (28 hrs blended)	$5,500 annual + $2,500 mods	$2,000
Year 3 maintenance	$5,500 (28 hrs blended)	$5,500 annual + $2,500 mods	$2,000
3-Year Total	$38,800	$32,500	$6,000
Year 1 share of 3-year spend	72%	51%	33%

Under hourly, 72% of the 3-year Sponsor cost lands in Year 1 — the worst possible time for a market entrant. Flat fee distributes the same scope evenly, freeing roughly USD 25,000 of Year 1 working capital for clinical evidence, MDSAP audit costs, or sales hires. (The USD 2,000 flat-fee figure assumes the manufacturer already holds CE marking or equivalent COR approval; full standard-pathway technical-file work is priced as a separate project.)

Scenario C: 5-Device Portfolio (3 Class IIa + 2 Class III)

3 Class IIa + 2 Class III devices, all CE-marked under EU MDR, entering the ARTG over a 6-month window in Year 1.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 total (5 devices)	$55,000–$95,000	$35,000–$60,000	$4,000 (5 inclusions tier)
Year 2	$18,000–$30,000	$14,000–$25,000	$4,000
Year 3	$18,000–$30,000	$14,000–$25,000	$4,000
3-Year Total	$91,000–$155,000	$63,000–$110,000	$12,000

Pure Global's 5-device tier (USD 4,000/year) is only USD 2,000 above the single-device tier. A 5-device Australia portfolio at the published rates costs less in Sponsor fees over three years than a single Class III device under hourly billing.

What "All-Inclusive" Actually Means: Scope Checklist

When proposals all claim to "include everything," the differences are in the fine print. Compare line by line.

Service Item	Hourly (typical)	Reg + Annual (typical)	Flat Fee — Pure Global
Acting as ARTG sponsor on the public TGA register	hourly	included	inherent to statutory role (Section 19A TG Act 1989)
Initial ARTG application via COR abbreviated pathway, based on existing CE marking	hourly	one-time setup + filing fee	included (published)
Australian Declaration of Conformity preparation	hourly	sometimes included	confirm with provider (not enumerated in published list)
TGA Business Services (TBS) account setup and management	hourly	included	confirm with provider (not enumerated; likely covered under "correspondence with authorities")
Modifications (labeling, IFU, manufacturer change, intended use)	hourly per mod	$400–$5,000 each	included (published — "modifications")
Section 41JA request for further information response	hourly	hourly above scope or per-event fee	likely included under published "correspondence with authorities" — confirm volume cap in writing
ARTG conditions of inclusion compliance correspondence	hourly	included or hourly	likely included under published "correspondence with authorities"
Annual ARTG charge invoice processing and forwarding	hourly	$200–$500/year handling fee	confirm with provider (not enumerated; verify no admin markup)
Reclassification handling (e.g., 2024–2025 IVD risk reclass)	hourly	$500–$3,500 each	likely included under published "modifications" — confirm in writing
Software / SaMD reclassification under post-Feb 2021 rules	hourly	$500–$3,500 each	likely included under published "modifications" — confirm in writing
MDSAP coordination (when used as conformity evidence)	hourly	sometimes included	confirm with provider (not enumerated)
CAB-issued Conformity Assessment Document upload	hourly	sometimes extra	likely included as part of published "preparation and submission" — confirm in writing
Renewals (where applicable)	hourly	included or per-event	included (published — "renewals")
Standard-pathway technical-file authoring (no CE/COR reference approval available)	hourly	separate project quote	not included (separate project quote)
Clinical Evaluation Report (CER) authoring	hourly	separate project quote	not included (separate project quote)
Receiving vigilance / recall correspondence from TGA	hourly	included or per-event	inherent to Sponsor statutory role (URPTG, MD Regulations 2002)
Drafting and submitting adverse event reports / recall notifications	hourly	hourly or per-event	separate — $200/hr ad-hoc (consulting menu)
Free-Sale certificate / export listing letters	hourly	$300–$800 each	separate — $200/hr ad-hoc (consulting menu)
TGA government fees (Application Assessment, ARTG Listing Annual, Audit Assessment)	passed through at cost	passed through at cost	passed through at cost (no markup)
Importation handling and customs brokerage	not in Sponsor scope	not in Sponsor scope	not included
MDSAP audit fees (paid to AO)	not in Sponsor scope	not in Sponsor scope	not included

The scope items that quietly drive Year-2-plus cost overruns are modifications, Section 41JA queries, IVD/SaMD reclassification handling, and annual ARTG charge admin fees — together 40–70% of post-Year-1 Sponsor spend. Whether they are inside or outside the flat fee is the single biggest line in any side-by-side comparison.

Recommended Reading

Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence

Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

What 2026 Australian TGA Regulatory Churn Costs Under Each Pricing Model

Australia's medical device regulatory environment between 2021 and 2026 has been one of the more active among major jurisdictions. The TGA Action Plan 2018–2025, SaMD classification reforms (Feb 2021), Personalised Medical Devices framework (Feb 2021), IVD risk reclassification ordinances (2024–2025), expanded CAB recognition pathway, and annual fees-and-charges indexation each force ARTG entries to file modifications, update declarations, or repackage documentation. Under hourly or reg-plus-annual, each is a billable event. Under flat fee, they are not.

Modification Volume from 2021–2026 TGA Rules

Regulation / Reform	Effective	Modification Type Triggered	Typical Modifications/Device
SaMD classification reforms	February 2021 (refinements 2023–2025)	SaMD reclassification, IFU/labeling updates	1–2 (software devices)
Personalised Medical Devices framework	February 2021, phased through 2024	Patient-matched / custom-made re-categorization	1–2 (patient-matched)
IVD risk reclassification ordinances	2024–2025	IVD reclassification, performance evaluation update	1–2 (IVDs)
Expanded CAB recognition pathway	2023–2025	Optional re-submission using CAB CAD	0–1
Patient implant registry expansion	2024–2025	New registry reporting obligations	0–1 (implants)
Periodic IFU/labeling and Sponsor guidance updates (e.g., January 2026)	Ongoing	Label, IFU, packaging text changes	1–2/year

Aggregated, a typical Class IIa device has absorbed 3–6 cumulative modifications since 2021. Class III/AIMD devices are closer to 5–10. SaMD products top the range at 6–10.

What That Modification Volume Costs You

Pricing Model	Per-Filing Cost	5-Year Cost (Class IIa, 5 filings)	5-Year Cost (Class III, 10 filings)
Hourly billing (3–8 hrs × $240 blended)	$720–$1,920	$3,600–$9,600	$7,200–$19,200
Reg fee + annual ($400–$5,000 each)	$400–$5,000	$2,000–$25,000	$4,000–$50,000
Pure Global flat fee	included	$0 incremental	$0 incremental

Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active the regulator is — not with how active you are.

What the TGA Has Queued for 2026–2028

Each of these is already in consultation or scheduled and will trigger fresh filings:

• Continued IVD reclassification finalisation through 2026, with new performance evaluation requirements in tranches.
• Cybersecurity guidance under the TGA Action Plan, binding expectations for connected devices expected 2026–2027.
• AI/ML SaMD follow-on guidance — predetermined change control plans, lifecycle update protocols, post-market performance reporting — expected 2026–2027.
• Patient implant registry expansion with new reporting hooks for Sponsors.
• Annual TGA fees-and-charges indexation every 1 July under the Therapeutic Goods (Charges) Act 1989.
• CAB recognition expansion — additional overseas CABs may be recognized 2026–2027, opening optional re-submission pathways.

A reasonable 2026–2028 forecast for an existing Class III device is 2–4 additional modifications — another USD 1,500–8,000 per device under hourly, $0 under flat fee. For a 5-device Class IIb/III portfolio, that is roughly USD 7,500–40,000 of P&L difference between flat fee and the alternatives.

When Flat Fee Wins, and When It Does Not

Flat fee is not universally the best choice. The decision framework:

Flat fee usually wins when:

• You expect to keep the device on the Australian market ≥3 years (the realistic case for almost every commercially active device — ARTG entries do not currently have a fixed renewal cycle).
• You have ≥2 devices in your Australia portfolio (tier discounts compound — Pure Global's 5-device tier is only USD 2,000 above the single-device tier).
• Your devices are in actively regulated categories (SaMD, IVD, AIMD, implantables) where 2026–2028 modification volume is forecast elevated.
• You hold CE marking under EU MDR or another COR-recognized approval and the Sponsor's role is the abbreviated pathway, not full technical-file authoring.
• You are pre-revenue or capital-constrained in Year 1 and want to smooth cash outflow.

Hourly billing might still win when:

• You are doing a one-time discovery exercise (TGA classification feasibility, SaMD reclassification analysis) and do not yet have an ARTG entry to maintain.
• You have a single Class I (non-sterile, non-measuring) device you expect to list once and never modify.
• You need ad-hoc strategic counsel outside an existing Sponsor relationship — Pure Global's USD 200/hour ad-hoc rate is materially below typical Australian Tier 1–2 hourly rates anyway.

Registration-fee-plus-annual is rarely the optimal choice on TCO grounds. It typically lands between hourly and flat fee on cost while preserving Year 1 front-loading and burying Year-2-plus modification fees in fine print.

Government Fees: A Quick Reference

Sponsor service fees are excluded from TGA government fees in every model. For completeness, the official 2026 TGA fees (effective from 1 July 2025 indexation, current at the time of writing) are:

Medical Devices

Filing	TGA Fee (AUD)	Approximate USD
Class I (other) — ARTG Listing Annual Fee	AUD 114	~$76
Class I (measuring or sterile) — ARTG Listing Annual Fee	AUD 828	~$552
Class IIa, IIb — ARTG Listing Annual Fee	AUD 1,230	~$820
Class III, AIMD — ARTG Listing Annual Fee	AUD 1,566	~$1,044
Class I (other, measuring, sterile) — Application Assessment Fee	AUD 621	~$414
Class IIa, IIb — Application Assessment Fee	AUD 1,187	~$791
Class III — Application Assessment Fee	AUD 1,530	~$1,020
Application Audit Assessment — Level 1	AUD 4,700	~$3,133
Application Audit Assessment — Level 2	AUD 17,288	~$11,525

IVDs

Filing	TGA Fee (AUD)	Approximate USD
Class 1, 2, 3, 4 — IVD ARTG Listing Annual Fee	AUD 893	~$595
Class 1, 2, 3, 4 — IVD Application Assessment Fee	AUD 1,187	~$791
Class 1, 2 — IVD Application Audit Assessment	AUD 7,981	~$5,321
Class 3, 4 — IVD Application Audit Assessment	AUD 15,341–24,189	~$10,227–$16,126

(USD conversions assume AUD 1.50 = USD 1.00. TGA fees are reset every 1 July under Schedule 5 of the Therapeutic Goods (Medical Devices) Regulations 2002 and indexed to a CPI/WPI-based formula. For a complete breakdown of conformity assessment routes, MDSAP audit cost, and clinical evidence requirements that drive total registration cost, see Australia TGA Medical Device Registration: The Complete Guide.)

The 3-layer Australian fee model — read carefully: (1) The Application Assessment Fee is a per-device, one-time fee at filing. (2) The ARTG Listing Annual Fee is a per-device, recurring fee invoiced every July — most foreign manufacturers underestimate this. (3) The Sponsor service fee sits on top. The Application Audit Assessment Fee is a conditional fourth layer applied if TGA selects your application for an audit.

Recommended Reading

Costa Rica Medical Device Registration Guide: Ministry of Health Process, Spanish Documentation, and LATAM Strategy

Regulatory Commercialization2026-04-24 · 13 min read

8 Questions to Ask Any Australian Sponsor Before You Sign

This checklist works regardless of which Sponsor you are evaluating. Demand explicit, written answers before signing — not verbal assurances during the sales call.

1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (Australian CPI? Wage Price Index? uncapped? indexed to TGA fee changes?).
2. How many modifications are included per year? Is the cap per device or per portfolio? What counts as a modification (labeling? IFU? manufacturer change? class change? intended use? ARTG conditions update?).
3. Are responses to Section 41JA TGA requests for further information included or billed separately? This is the single largest hidden Year-1 expense for borderline Class IIb/III devices and the most commonly omitted scope item in industry RFPs.
4. What is the per-hour rate for out-of-scope work? Pure Global publishes USD 200/hour. Some Australian firms advertise low base fees and charge AUD 500–700+/hour for anything outside scope.
5. Who handles the ARTG annual charge invoice — and is there a handling fee on top of the passthrough? The annual charge ranges AUD 114–1,566 per device. Some Sponsors add a USD 200–500 admin fee on top; flat-fee Sponsors should fold the handling into the annual fee.
6. What are the termination terms? Pure Global publishes 50% payoff of remaining contract value. Many competitors require full payoff or 12-month notice. This matters more than the headline price.
7. Does the Sponsor hold the ARTG entry in its own corporate name or in trust for the manufacturer? If a distributor or Sponsor refuses to commit in writing to a no-cost transfer-out, that is a lock-in indicator. The TGA's sponsor transfer process requires the outgoing Sponsor's written cooperation.
8. How does the Sponsor handle reclassifications driven by regulatory churn (SaMD, IVD risk reclass, Personalised Medical Devices)? Confirm in writing whether reclassification handling is inside the annual fee or billed separately — this is where 2024–2026 IVD reclassifications have generated unbudgeted invoices for hourly and reg-plus-annual customers.

If a Sponsor refuses to answer any of these in writing, that is the answer to the question.

Australian Sponsor Switching Playbook: How to Leave Without Getting Trapped

The single most expensive mistake in Australian Sponsor selection is signing a contract you cannot exit affordably. Many foreign manufacturers discover, 18 months in, that their Sponsor is mediocre but switching costs more than staying. This section is the operational playbook competitors avoid publishing.

The TGA Sponsor Transfer Procedure

The TGA permits transfer of sponsor for an ARTG entry. The mechanic:

Step	Who Performs	Typical Duration	Notes
1. Manufacturer issues new Letter of Authority to the incoming Sponsor	Manufacturer + new Sponsor	1–2 weeks	Must reference each ARTG number being transferred
2. Outgoing Sponsor agrees in writing to the transfer and signs the TGA transfer form	Outgoing Sponsor	0 days to 6 months	This is the choke point. Some firms drag this through the full notice period.
3. New Sponsor lodges the sponsor transfer application via TGA Business Services	New Sponsor	30–60 days TGA processing	Class I listings faster; registered devices slower
4. Outgoing Sponsor confirms cancellation of association	Outgoing Sponsor	30 days	Mostly mechanical
5. Updated ARTG entry reflects new sponsor on TGA public register	TGA	Within days of approval	Public via ARTG search
Total realistic timeline		60–180 days for listed devices, 90–240 days for registered devices	Faster if outgoing Sponsor cooperates

Australian-specific timing point: The ARTG annual charge is invoiced in July; the entity holding the ARTG entry on invoice day pays. Time transfers between January and April for a clean fiscal-year handoff.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your Sponsor agreement is often more economically consequential than the headline annual fee. Common terms in the Australian market:

Termination Term	Typical Industry Practice	Pure Global Published Term
Notice period required	6–12 months	None — termination effective on contract anniversary
Payoff of remaining contract value on early exit	100% of remaining contract	50% payoff of remaining contract
Transfer letter / TGA form delivery commitment	Within "reasonable time" (undefined)	Standard contract term
Separate "transfer fee" charged at exit	AUD 1,500–5,000 typical	None
Right to withhold ARTG transfer cooperation	Sometimes asserted	Explicitly waived

A typical industry contract requiring 12 months notice plus 100% payoff makes mid-contract switching on a USD 5,000/year deal cost roughly USD 17,500 (notice + 2-year payoff + transfer fee) before you pay the new Sponsor a cent — more than 8 years of flat-fee under Pure Global's published single-inclusion rate.

The Distributor-as-Sponsor Lock-In Trap

The most common trap for first-time Australia entrants: letting the in-country distributor double as the Sponsor. Up front this looks efficient — one relationship, no separate retainer, the distributor often offers Sponsor services "free" as part of the commercial deal. The economic reality is harsher:

• Switching distributors often means a sponsor transfer plus renegotiated commercials simultaneously. The outgoing distributor has no incentive to cooperate on the TGA transfer if you are terminating them commercially. Cases of ARTG entries sitting in limbo for 6–12 months are common.
• The distributor has implicit veto power. Add a second importer? They can refuse parallel Sponsor inclusions. Renegotiate margins? They can drag the transfer.
• The "free Sponsor" is priced into distributor margin. Industry practice is a 5–15% commercial markup. For a USD 5M/year Australia business, that is USD 250,000–750,000/year in implicit Sponsor cost.
• The Sponsor — not the manufacturer — is who TGA holds liable. If you are not the Sponsor, you are not the entity TGA contacts on a recall.

The right structure: an independent professional Sponsor holds the ARTG entry, and one or more distributors are commercial importers sourcing from it. Switching distributors becomes a commercial decision, not a regulatory one. You pay USD 2,000–4,000/year for the Sponsor and recapture the 5–15% distributor margin.

Clean Switching: 7-Step Sequencing

1. Sign the new Sponsor first, contract conditional on successful TGA transfer of named ARTG entries.
2. Generate fresh Letters of Authority in parallel, listing each ARTG number to be transferred.
3. Time the notice letter to land 30 days before the contract anniversary to minimize early-termination cost — and ideally close the transfer before 30 June to keep the ARTG annual charge clean.
4. Cite specific contract clauses in your termination letter (the transfer cooperation commitment in particular).
5. File the TGA sponsor transfer application the day you receive the outgoing Sponsor's signature.
6. Hold importation continuous — ARTG numbers themselves do not change on a sponsor transfer, but the responsible party does.
7. Confirm vigilance-mailbox handover — TGA routes incident reports and Section 41JA letters to the Sponsor of record.

A well-executed switch costs USD 2,000–5,000 and 60–120 days. A poorly executed switch can cost a year of market access. The contract termination clause is the upstream variable that determines which one you get.

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

We modeled the same scope — a single Class IIa medical device entering Australia under the COR abbreviated pathway (CE marking under EU MDR as the reference approval), 3-year Sponsor relationship — under three pricing structures: Pure Global (rates verified on its public pricing page), plus two composite industry quotes (hourly-billing and reg-plus-annual) built from typical RFP responses from Emergo Australia, MDSS, MedEnvoy, KD&A, Asia Actual, and similarly-positioned firms.

The composite columns use midpoints; the Pure Global column uses the published rate. Competitor firms are not named individually because, unlike Pure Global, they do not publish prices and we cannot publish proposal data without consent.

Same Scope, Three Models, 3-Year Total

Scope baseline: 1 Class IIa medical device, ARTG inclusion via abbreviated COR pathway under existing EU MDR CE marking, foreign manufacturer with no Australian entity, 3-year contract, 1–2 modifications/year, 1 Section 41JA query in Year 1.

Line Item	Pure Global (Flat Fee)	Composite Hourly Quote	Composite Reg+Annual Quote
Year 1 — initial filing & Sponsor setup (COR abbreviated pathway, CE marking reference)	$2,000 (annual fee — published)	$7,800 (40 hrs × $195 blended)	$5,500 ($2,500 setup + $3,000 filing)
Year 1 — Australian Declaration of Conformity preparation	confirm in writing — not enumerated on published list	$1,200 (5 hrs T2)	$500 separately
Year 1 — Section 41JA response	likely included under "correspondence with authorities" — confirm volume cap	$1,400 (6 hrs T2)	$1,000–$1,800 separately
Year 1 — 1 modification	included (published — "modifications")	$570 (3 hrs T2)	$400–$1,500
Year 1 — annual ARTG charge handling	confirm in writing — not enumerated; verify no admin markup	$400 (admin time)	$200–$500 handling fee
Year 1 total	$2,000	$11,370	$7,600–$10,300
Year 2 — annual maintenance	$2,000	$3,400 (18 hrs blended)	$2,500–$3,500 base
Year 2 — 1–2 modifications	included	$750	$400–$3,000
Year 3 — annual maintenance	$2,000	$3,400	$2,500–$3,500
Year 3 — 1–2 modifications	included	$750	$400–$3,000
3-Year Total	$6,000	$19,670	$13,800–$23,300

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical Australian Sponsor RFP responses observed by MedDeviceGuide; individual firm numbers vary.)

Key Takeaways from the Comparison

• Pure Global at the published rate is 3.3x cheaper than the composite hourly quote over 3 years, and 2.3x to 3.9x cheaper than the composite reg+annual quote.
• The gap widens in Years 2–3 if modifications run above average — likely for most software, IVD, and connected devices given 2026 TGA churn.
• The reg-plus-annual bracket is wide because providers vary enormously on whether modifications, Section 41JA responses, and ARTG annual charge handling are inside the annual fee. Read every "included" claim line by line.
• The flat-fee model is insulated from invoice variance. The only variable you control is how many ARTG inclusions you sign up for.

Why Composite Instead of Named Competitors

No other major Australian Sponsor provider (Emergo Australia, MDSS, MedEnvoy, KD&A, Asia Actual, Adjutor, Archer Emery, EMC Healthcare, Compliance MS) publishes its prices, so naming Firm X with a specific number invites disputes we cannot resolve without violating NDAs. Every firm's quote also varies by negotiation, scope, and volume — single-firm naming gives a misleadingly precise picture. The point of the analysis is the structural difference between pricing models, not which competitor is best.

For firm-specific pricing, issue your own RFP. The next section gives you a template designed to force apples-to-apples comparisons.

Recommended Reading

CPT, HCPCS, and ICD Coding Strategy for Medical Devices: Reimbursement Pathway Guide

Reimbursement & Market Access Commercialization2026-04-24 · 13 min read

Australian Sponsor RFP Template Copy and Paste

Most Australian Sponsor RFPs come back in three different formats with three different scope inclusion lists. Use the template below to force every responding firm into the same structure.

---

Subject: Request for Proposal — Australian Sponsor Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is evaluating Australian Sponsor service providers for our medical device portfolio entering or maintaining presence in the Australian market. We are issuing this RFP to [N] firms and request a written proposal by [date].

Portfolio Scope

#	Device Name	TGA Class	IVD or MD	Pathway (COR Abbreviated / Standard)	Reference Approval (CE Marking / FDA / Health Canada / PMDA / HSA)	Currently on ARTG?
1	[Device A]	[I / IIa / IIb / III / AIMD]	[MD / IVD]	[COR / Standard]	[e.g., EU MDR CE 2026/01]	[Yes / No]
2	[Device B]

Contract Term: We anticipate a [3-year / 5-year] Sponsor relationship.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.

Service Item	Year 1 Cost	Year 2 Cost	Year 3 Cost	Inclusion (Y/N)	Per-Unit Rate if Separate
Acting as Sponsor of record on ARTG
Initial ARTG application (COR abbreviated pathway) per device
Australian Declaration of Conformity preparation
TGA Business Services account management
Modifications — please state limit per device per year
Section 41JA response — please state inclusion
ARTG annual charge invoice handling — passthrough only or with markup?
Reclassification handling (SaMD, IVD risk, Personalised Medical Devices)
Vigilance / adverse event reporting drafting and submission
Recall coordination under URPTG
Free-Sale certificate issuance
Out-of-scope hourly rate (T1 / T2 / T3)

Required Disclosures

1. Annual fee escalation clause — fixed, CPI-linked, WPI-linked, indexed to TGA fee schedule, or uncapped?
2. Notice period required for non-renewal at end of term.
3. Early termination payoff — what percentage of remaining contract value?
4. Sponsor transfer cooperation commitment in days from termination notice.
5. Any separate "transfer fee" charged at exit — yes/no, amount.
6. TGA government fees — confirm passed through at cost without markup (Application Assessment Fee, ARTG Listing Annual Fee, Application Audit Assessment Fee).
7. Whether you hold ARTG entries in your corporate name as agent for the manufacturer, and whether you assert any right to delay or refuse a sponsor transfer.
8. Confirm your Australian corporate entity (ACN) and that you meet the Section 19A residency/incorporation requirement.

Evaluation Criteria

We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) termination clause flexibility, (4) responsiveness during this RFP, (5) TGA filing track record (please attach 2–3 references with ARTG numbers we can verify on the public register).

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]

---

This template forces every Sponsor to price the same scope. The line items where firms diverge most — modifications, Section 41JA responses, ARTG annual charge handling, reclassification handling, and termination clauses — are the items it forces them to disclose explicitly.

Frequently Asked Questions

Is an Australian Sponsor the same as a distributor?

No. The Sponsor is the legal entity defined under Section 19A of the Therapeutic Goods Act 1989 that holds the ARTG entry and acts as TGA's regulatory point of contact. A distributor imports and sells commercially. The same entity can play both roles, but combining them is generally a bad idea — if the commercial relationship sours, the distributor controls the ARTG entry and you cannot leave without a sponsor transfer that requires their cooperation.

Can I be my own Sponsor?

Only if you have an Australian legal entity — either an individual resident in Australia or a body corporate incorporated under Australian law. Most foreign manufacturers find the cost of standing up and maintaining an Australian regulatory entity (ASIC filings, local director, ABN/ACN administration, plus regulatory headcount) exceeds the cost of an independent professional Sponsor for the first 5–10 devices.

How long does a Sponsor transition take if I want to switch?

Typically 60–120 days for Class I listings and 90–240 days for registered devices (Class IIa, IIb, III, AIMD, IVDs requiring assessment). Pure Global's standard 50% remaining-contract-value early-termination clause is among the more buyer-friendly in the industry — many Sponsors require full remaining contract payoff plus 6–12 months of notice.

Does the Sponsor pay TGA fees on my behalf?

Yes — the Sponsor invoices and pays TGA on your behalf, but the Application Assessment Fee, ARTG Listing Annual Fee, and any Application Audit Assessment Fee are reimbursed at cost. Reputable Sponsors do not mark up government fees. The ARTG Listing Annual Fee recurs every July for the life of the listing — budget it as an operating cost, not a one-off.

What happens if my device gets a Section 41JA TGA request for further information?

Under hourly billing, every hour spent on the response is billed. Under registration-plus-annual, Section 41JA responses are sometimes inside scope and sometimes billed separately. Under Pure Global's flat-fee model, Section 41JA responses are inside the annual fee. Confirm this in writing — it can be the single largest year-2 expense for borderline Class IIb/III devices.

Can I negotiate the flat-fee price?

Pure Global publishes the price, which means the published per-tier rate is the rate. Negotiable variables are typically scope (number of devices, contract length) rather than the per-device fee. For 6+ device portfolios, custom pricing applies.

What about MDSAP — does that reduce my Sponsor cost?

No, but it can reduce TGA Application Audit Assessment fees and streamline review for some classes. MDSAP is a quality system certification scheme, not a Sponsor function. Sponsor fees cover the ARTG-side work; MDSAP audits (typically USD 15,000–35,000 per annual surveillance) are paid separately to the MDSAP Auditing Organization.

How does Australian Sponsor cost compare to other major markets?

Australia's Sponsor cost (USD 2,000–4,000/year flat fee on the published Pure Global table for 1–5 inclusions) sits between Brazil's BRH (USD 2,000–14,000/year) and Japan's DMAH (USD 15,000–50,000/year). See Medical Device Registration Cost by Country: 2026 Global Comparison for the full benchmark.

Bottom Line

Australia's TGA government fees are not where Australia registration budgets get blown up — they are public, indexed every 1 July, and predictable. The line item that wrecks budgets is the Australian Sponsor service fee, specifically the cash flow shape of when those fees hit. Hourly billing front-loads 60–75% of 3-year cost into Year 1; registration-fee-plus-annual front-loads 50–55%; flat all-inclusive billing flattens it to roughly 33% per year — the only model that aligns with how MedTech revenue actually scales in a new market. Treat all three fee layers (Application Assessment, ARTG Listing Annual, Sponsor) as recurring operating costs. Negotiate the third hard. Ask the 8 questions before you sign.

Related Guides

• Australia TGA Medical Device Registration: The Complete Guide
• Medical Device Registration Cost by Country: 2026 Global Comparison
• Medical Device Regulatory Consulting Hourly Rates by Region
• Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison